Stem cells for the treatment of neurodegenerative diseases

Molecules

Volumn 15, Issue 10, 2010, Pages 6743-6758

  Wu, Yong Ping ^a   Chen, Wei Shan ^a   Teng, Chong ^a   Zhang, Ning ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Neurodegenerative diseases; Stem cell; Treatment

Indexed keywords

EID: 78149441145     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15106743     Document Type: Article

References (121)

1. Kim, S.U.; de Vellis, J. Stem cell-based cell therapy in neurological diseases: A review. J. Neurosci. Res. 2009, 87, 2183-2200.
2. Lindvall, O.; Kokaia, Z.; Martinez-Serrano, A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 2004, 10, S42-S50.
3. Cui, Y.F.; Hargus, G.; Xu, J.C.; Schmid, J.S.; Shen, Y.Q.; Glatzel, M.; Schachner, M.; Bernreuther, C. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Brain 2010, 133, 189-204.
4. Grunt, R.F. Embryonic stem-cell research. N. Engl. J. Med. 2004, 351, 1797-1798.
5. Daley, G.Q. Missed opportunities in embryonic stem-cell research. N. Engl. J. Med. 2004, 351, 627-628
6. Yang, D.; Zhang, Z.J.; Oldenburg, M.; Ayala, M.; Zhang, S.C. Human embryonic stem cellderived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 2008, 26, 55-63.
7. Glass, C.K.; Saijo, K.; Winner, B.; Marchetto, M.C.; Gage, F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140, 918-934.
8. Dawson, T.M.; Dawson, V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302, 819-822.
9. Burnstein, R.M.; Foltynie, T.; He, X.; Menon, D.K.; Svendsen, C.N.; Caldwell, M.A. Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. Int. J. Biochem. Cell Biol. 2004, 36, 702-713.
10. Kim, J.H.; Auerbach, J.M.; Rodriguez-Gomez, J.A.; Velasco, I.; Gavin, D.; Lumelsky, N.; Lee, S.H.; Nguyen, J.; Sanchez-Pernaute, R.; Bankiewicz, K.; McKay, R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002, 418, 50-56.
11. Prokai-Tatrai, K.; Prokai, L. Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents. Molecules 2009, 14, 633-654.
12. Prokai-Tatrai, K.; Perjesi, P.; Rivera-Portalatin, N.M.; Simpkins, J.W.; Prokai, L. Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative. Steroids 2008, 73, 280-288.
13. Cova, L.; Armentero, M.T.; Zennaro, E.; Calzarossa, C.; Bossolasco, P.; Busca, G.; Lambertenghi Deliliers, G.; Polli, E.; Nappi, G.; Silani, V.; Blandini, F. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res. 2010, 1311, 12-27.
14. Venkataramana, N.K.; Kumar, S.K.; Balaraju, S.; Radhakrishnan, R.C.; Bansal, A.; Dixit, A.; Rao, D.K.; Das, M.; Jan, M.; Gupta, P.K.; Totey, S.M. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl. Res. 2010, 155, 62-70.
15. Hedlund, E.; Pruszak, J.; Lardaro, T.; Ludwig, W.; Vinuela, A.; Kim, K.S.; Isacson, O. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 2008, 26, 1526-1536.
16. Mine, Y.; Hayashi, T.; Yamada, M.; Okano, H.; Kawase, T. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain. Neurosurgery 2009, 65, 741-753.
17. McLeod, M.; Hong, M.; Mukhida, K.; Sadi, D.; Ulalia, R.; Mendez, I. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. Eur. J. Neurosci. 2006, 24, 361-370.
18. Ourednik, V.; Ourednik, J.; Xu, Y.F.; Zhang, Y.; Lynch, W.P.; Snyder, E.Y.; Schachner, M. Cross-Talk Between Stem Cells and the Dysfunctional Brain is Facilitated by Manipulating the Niche: Evidence from an Adhesion Molecule. Stem Cells 2009, 27, 2846-2856.
19. Oizumi, H.; Hayashita-Kinoh, H.; Hayakawa, H.; Arai, H.; Furuya, T.; Ren, Y.R.; Yasuda, T.; Seki, T.; Mizuno, Y.; Mochizuki, H. Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease. Neurosci. Res. 2008, 60, 15-21.
20. Isacson, O. Cell therapy ahead for Parkinson's disease. Science 2009, 326, 1060.
21. Akerud, P.; Holm, P.C.; Castelo-Branco, G.; Sousa, K.; Rodriguez, F.J.; Arenas, E. Persephinoverexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease. Mol. Cell. Neurosci. 2002, 21, 205-222.
22. Shin, J.H.; Dawson, V.L.; Dawson, T.M. SnapShot: Pathogenesis of Parkinson's Disease. Cell 2009, 139, e1-e2.
23. Marchetto, M.C.; Winner, B.; Gage, F.H. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum. Mol. Genet. 2010, 19, R71-R76.
24. Nakamura, T.; Lipton, S.A. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases. Apoptosis 2010. doi: 10.1007/s10495-010-0476-x.
25. Steiner, B.; Wolf, S.; Kempermann, G. Adult neurogenesis and neurodegenerative disease. Regen. Med. 2006, 1, 15-28.
26. Zietlow, R.; Lane, E.L.; Dunnett, S.B.; Rosser, A.E. Human stem cells for CNS repair. Cell Tissue Res. 2008, 331, 301-322.
27. Dunnett, S.B.; Rosser, A.E. Stem cell transplantation for Huntington's disease. Exp. Neurol. 2007, 203, 279-292.
28. Kim, M.; Lee, S.T.; Chu, K.; Kim, S.U. Stem cell-based cell therapy for Huntington disease: A review. Neuropathology 2008, 28, 1-9.
29. McKay, R. Stem cells in the central nervous system. Science 1997, 276, 66-71.
30. Keene, C.D.; Rodrigues, C.M.P.; Eich, T.; Chhabra, M.S.; Steer, C.J.; Low, W.C. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2002, 99, 10671-10676.
31. Ramaswamy, S.; Shannon, K.M.; Kordower, J.H. Huntington's disease: Pathological mechanisms and therapeutic strategies. Cell Transplant. 2007, 16, 301-312.
32. Johann, V.; Schiefer, J.; Sass, C.; Mey, J.; Brook, G.; Kruttgen, A.; Schlangen, C.; Bernreuther, C.; Schachner, M.; Dihne, M.; Kosinski, C.M. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Exp. Brain Res. 2007, 177, 458-470.
33. Cherubini, A.; Spoletini, I.; Peran, P.; Luccichenti, G.; Di Paola, M.; Sancesario, G.; Gianni, W.; Giubilei, F.; Bossu, P.; Sabatini, U.; Caltagirone, C.; Spalletta, G. A multimodal MRI investigation of the subventricular zone in mild cognitive impairment and Alzheimer's disease patients. Neurosci. Lett. 2010, 469, 214-218.
34. Wang, J.M.; Singh, C.; Liu, L.; Irwin, R.W.; Chen, S.; Chung, E.J.; Thompson, R.F.; Brinton, R.D. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2010, 107, 6498-6503.
35. McBride, J.L.; Behrstock, S.P.; Chen, E.Y.; Jakel, R.J.; Siegel, I.; Svendsen, C.N.; Kordower, J.H. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J. Comp. Neurol. 2004, 475, 211-219.
36. Snyder, B.R.; Chiu, A.M.; Prockop, D.J.; Chan, A.W. Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease. Plos One 2010, 5, e9347.
37. Krystkowiak, P.; Gaura, V.; Labalette, M.; Rialland, A.; Remy, P.; Peschanski, M.; Bachoud-Levi, A.C. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. Plos One 2007, 2, e166.
38. Lorincz, M.T.; Zawistowski, V.A. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells. Mol. Cell Neurosci. 2009, 40, 1-13.
39. Kim, S.U. Genetically engineered human neural stem cells for brain repair in neurological diseases. Brain Develop 2007, 29, 193-201.
40. Clelland, C.D.; Barker, R.A.; Watts, C. Cell therapy in Huntington disease. Neurosurg. Focus 2008, 24, E9.
41. Ebert, A.D.; Barber, A.E.; Heins, B.M.; Svendsen, C.N. Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease. Exp. Neurol. 2010, 224, 155-162.
42. Yang, C.R.; Yu, R.K. Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease. J. Neurosci. Res. 2009, 87, 26-33.
43. Roberts, T.J.; Price, J.; Williams, S.C.; Modo, M. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience 2006, 139, 1187-1199.
44. McBride, J.L.; Ramaswamy, S.; Gasmi, M.; Bartus, R.T.; Herzog, C.D.; Brandon, E.P.; Zhou, L.; Pitzer, M.R.; Berry-Kravis, E.M.; Kordower, J.H. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2006, 103, 9345-9350.
45. Laowtammathron, C.; Cheng, E.; Cheng, P.H.; Snyder, B.R.; Yang, S.H.; Johnson, Z.; Lorthongpanich, C.; Kuo, H.C.; Parnpai, R.; Chan, A.W. Monkey hybrid stem cells develop cellular features of Huntington's disease. BMC Cell Biol. 2010, 11, 12.
46. Mareschi, K.; Novara, M.; Rustichelli, D.; Ferrero, I.; Guido, D.; Carbone, E.; Medico, E.; Madon, E.; Vercelli, A.; Fagioli, F. Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types. Exp. Hematol. 2006, 34, 1563-1572.
47. Pineda, J.R.; Rubio, N.; Akerud, P.; Urban, N.; Badimon, L.; Arenas, E.; Alberch, J.; Blanco, J.; Canals, J.M. Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells. Gene Ther. 2007, 14, 118-128.
48. Molero, A.E.; Gokhan, S.; Gonzalez, S.; Feig, J.L.; Alexandre, L.C.; Mehler, M.F. Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2009, 106, 21900-21905.
49. Huang, A.H.; Snyder, B.R.; Cheng, P.H.; Chan, A.W. Putative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice. Stem Cells 2008, 26, 2654-2663.
50. Bantubungi, K.; Blum, D.; Cuvelier, L.; Wislet-Gendebien, S.; Rogister, B.; Brouillet, E.; Schiffmann, S.N. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Mol. Cell Neurosci. 2008, 37, 454-470.
51. Oliveira, A.A., Jr.; Hodges, H.M. Alzheimer's disease and neural transplantation as prospective cell therapy. Curr. Alzheimer Res. 2005, 2, 79-95.
52. Lee, J.K.; Jin, H.K.; Endo, S.; Schuchman, E.H.; Carter, J.E.; Bae, J.S. Intracerebral Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Amyloid-Beta Deposition and Rescues Memory Deficits in Alzheimer's Disease Mice by Modulation of Immune Responses. Stem Cells 2010, 28, 329-343.
53. Blurton-Jones, M.; Kitazawa, M.; Martinez-Coria, H.; Castello, N.A.; Muller, F.J.; Loring, J.F.; Yamasaki, T.R.; Poon, W.W.; Green, K.N.; LaFerla, F.M. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. USA 2009, 106, 13594-13599.
54. Wu, S.; Sasaki, A.; Yoshimoto, R.; Kawahara, Y.; Manabe, T.; Kataoka, K.; Asashima, M.; Yuge, L. Neural stem cells improve learning and memory in rats with Alzheimer's disease. Pathobiology 2008, 75, 186-194.
55. Ryu, J.K.; Cho, T.; Wang, Y.T.; McLarnon, J.G. Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain. J. Neuroinflammation 2009, 6, 39.
56. Wu, L.; Sluiter, A.A.; Guo, H.F.; Balesar, R.A.; Swaab, D.F.; Zhou, J.N.; Verwer, R.W. Neural stem cells improve neuronal survival in cultured postmortem brain tissue from aged and Alzheimer patients. J. Cell Mol. Med. 2008, 12, 1611-1621.
57. Bergmans, B.A.; Shariati, S.A.M.; Habets, R.L.P.; Verstreken, P.; Schoonjans, L.; Muller, U.; Dotti, C.G.; De Strooper, B. Neurons Generated from APP/APLP1/APLP2 Triple Knockout Embryonic Stem Cells Behave Normally in Vitro and in Vivo: Lack of Evidence for a Cell Autonomous Role of the Amyloid Precursor Protein in Neuronal Differentiation. Stem Cells 2010, 28, 399-406.
58. Zhongling, F.; Gang, Z.; Lei, Y. Neural stem cells and Alzheimer's disease: Challenges and hope. Am. J. Alzheimers Dis. Other Demen. 2009, 24, 52-57.
59. Holtzman, D.M. Alzheimer's disease: Moving towards a vaccine. Nature 2008, 454, 418-420.
60. Waldau, B.; Shetty, A.K. Behavior of neural stem cells in the Alzheimer brain. Cell Mol. Life Sci. 2008, 65, 2372-2384.
61. Lee, J.K.; Jin, H.K.; Bae, J.S. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci. Lett. 2009, 450, 136-141.
62. Wang, Q.; Matsumoto, Y.; Shindo, T.; Miyake, K.; Shindo, A.; Kawanishi, M.; Kawai, N.; Tamiya, T.; Nagao, S. Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. J. Med. Invest. 2006, 53, 61-69.
63. Lee, H.J.; Lee, J.K.; Lee, H.; Carter, J.E.; Chang, J.W.; Oh, W.; Yang, Y.S.; Suh, J.G.; Lee, B.H.; Jin, H.K.; Bae, J.S. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol. Aging 2010. doi: 10.1016/j.neurobiolaging.2010.03. 024.
64. Salloway, S.; Mintzer, J.; Weiner, M.F.; Cummings, J.L. Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement. 2008, 4, 65-79.
65. Sugaya, K. Possible use of autologous stem cell therapies for Alzheimer disease. Neurobiol. Aging 2004, 25, S24-S25.
66. Xuan, A.G.; Luo, M.; Ji, W.D.; Long, D.H. Effects of engrafted neural stem cells in Alzheimer's disease rats. Neurosci. Lett. 2009, 450, 167-171.
67. Imitola, J. Prospects for neural stem cell-based therapies for neurological diseases. Neurotherapeutics 2007, 4, 701-714.
68. Sugaya, K.; Merchant, S. How to Approach Alzheimer's Disease Therapy Using Stem Cell Technologies. J. Alzheimers Dis. 2008, 15, 241-254.
69. Santilli, G.; Lamorte, G.; Carlessi, L.; Ferrari, D.; Rota Nodari, L.; Binda, E.; Delia, D.; Vescovi, A.L.; De Filippis, L. Mild hypoxia enhances proliferation and multipotency of human neural stem cells. Plos One 2010, 5, e8575.
70. Heese, K.; Low, J.W.; Inoue, N. Nerve growth factor, neural stem cells and Alzheimer's disease. Neurosignals 2006, 15, 1-12.
71. Mucke, L. Neuroscience: Alzheimer's disease. Nature 2009, 461, 895-897.
72. Sugaya, K.; Kwak, Y.D.; Ohmitsu, O.; Marutle, A.; Greig, N.H.; Choumrina, E. Practical issues in stem cell therapy for Alzheimer's disease. Curr. Alzheimer Res. 2007, 4, 370-377.
73. Giacobini, E.; Becker, R.E. One hundred years after the discovery of Alzheimer's disease. A turning point for therapy? J. Alzheimers Dis. 2007, 12, 37-52.
74. Papadeas, S.T.; Maragakis, N.J. Advances in stem cell research for Amyotrophic Lateral Sclerosis. Curr. Opin. Biotechnol. 2009, 20, 545-551.
75. Yan, J.; Xu, L.; Welsh, A.M.; Chen, D.; Hazel, T.; Johe, K.; Koliatsos, V.E. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 2006, 24, 1976-1985.
76. Silani, V.; Calzarossa, C.; Cova, L.; Ticozzi, N. Stem cells in amyotrophic lateral sclerosis: Motor neuron protection or replacemenť CNS Neurol. Disord. Drug Target. 2010, 9, 314-324.
77. Silani, V.; Cova, L.; Corbo, M.; Ciammola, A.; Polli, E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004, 364, 200-202.
78. Yang, E.J.; Jiang, J.H.; Lee, S.M.; Hwang, H.S.; Lee, M.S.; Choi, S.M. Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model. J. Neuroimmunol. 2010, 223, 84-91.
79. Thonhoff, J.R.; Ojeda, L.; Wu, P. Stem cell-derived motor neurons: Applications and challenges in amyotrophic lateral sclerosis. Curr. Stem Cell Res. Ther. 2009, 4, 178-199.
80. Lepore, A.C.; Maragakis, N.J. Targeted stem cell transplantation strategies in ALS. Neurochem. Int. 2007, 50, 966-975.
81. de Aguilar, J.L.G.; Echaniz-Laguna, A.; Fergani, A.; Rene, F.; Meininger, V.; Loeffler, J.P.; Dupuis, L. Amyotrophic lateral sclerosis: All roads lead to Rome. J. Neurochem. 2007, 101, 1153-1160.
82. Neusch, C.; Bahr, M.; Schneider-Gold, C. Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease? Muscle Nerve 2007, 35, 712-724.
83. Karumbayaram, S.; Kelly, T.K.; Paucar, A.A.; Roe, A.J.; Umbach, J.A.; Charles, A.; Goldman, S.A.; Kornblum, H.I.; Wiedau-Pazos, M. Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis. Model Mech. 2009, 2, 189-195.
84. Di Giorgio, F.P.; Boulting, G.L.; Bobrowicz, S.; Eggan, K.C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 2008, 3, 637-648.
85. Vercelli, A.; Mereuta, O.M.; Garbossa, D.; Muraca, G.; Mareschi, K.; Rustichelli, D.; Ferrero, I.; Mazzini, L.; Madon, E.; Fagioli, F. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2008, 31, 395-405.
86. Calvo, A.; Moglia, C.; Balma, M.; Chio, A. Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: A therapeutic opportunity? CNS Neurol. Disord. Drug Target. 2010, 9, 325-330.
87. Suzuki, M.; McHugh, J.; Tork, C.; Shelley, B.; Klein, S.M.; Aebischer, P.; Svendsen, C.N. GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS. Plos One 2007, 2, e689.
88. Inoue, H. Neurodegenerative disease-specific induced pluripotent stem cell research. Exp. Cell Res. 2010. 316, 2560-2564.
89. Mazzini, L.; Ferrero, I.; Luparello, V.; Rustichelli, D.; Gunetti, M.; Mareschi, K.; Testa, L.; Stecco, A.; Tarletti, R.; Miglioretti, M.; Fava, E.; Nasuelli, N.; Cisari, C.; Massara, M.; Vercelli, R.; Oggioni, G.D.; Carriero, A.; Cantello, R.; Monaco, F.; Fagioli, F. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp. Neurol. 2010, 223, 229-237.
90. Mazzini, L.; Vercelli, A.; Mareschi, K.; Ferrero, I.; Testa, L.; Fagioli, F. Mesenchymal stem cells for ALS patients. Amyotroph. Lateral Scler. 2009, 10, 123-124.
91. Corti, S.; Locatelli, F.; Papadimitriou, D.; Del Bo, R.; Nizzardo, M.; Nardini, M.; Donadoni, C.; Salani, S.; Fortunato, F.; Strazzer, S.; Bresolin, N.; Comi, G.P. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 2007, 130, 1289-1305.
92. Boillee, S.; Vande Velde, C.; Cleveland, D.W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52, 39-59.
93. Kim, H.; Kim, H.Y.; Choi, M.R.; Hwang, S.; Nam, K.H.; Kim, H.C.; Han, J.S.; Kim, K.S.; Yoon, H.S.; Kim, S.H. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci. Lett. 2010, 468, 190-194.
94. Garbuzova-Davis, S.; Sanberg, P.R. Feasibility of cell therapy for amyotrophic lateral sclerosis. Exp. Neurol. 2009, 216, 3-6.
95. Choi, M.R.; Kim, H.Y.; Park, J.Y.; Lee, T.Y.; Baik, C.S.; Chai, Y.G.; Jung, K.H.; Park, K.S.; Roh, W.; Kim, K.S.; Kim, S.H. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2010, 472, 94-98.
96. Gornall, J. Stem cell renegades or pioneers? BMJ 2010, 340, c2041.
97. Mazzini, L.; Mareschi, K.; Ferrero, I.; Vassallo, E.; Oliveri, G.; Nasuelli, N.; Oggioni, G.D.; Testa, L.; Fagioli, F. Stem cell treatment in Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2008, 265, 78-83.
98. Savitz, S.I.; Rosenbaum, D.M.; Dinsmore, J.H.; Wechsler, L.R.; Caplan, L.R. Cell transplantation for stroke. Ann. Neurol. 2002, 52, 266-275.
99. Cui, X.; Chopp, M.; Zacharek, A.; Roberts, C.; Lu, M.; Savant-Bhonsale, S.; Chen, J. Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol. Dis. 2009, 36, 35-41.
100. Hayase, M.; Kitada, M.; Wakao, S.; Itokazu, Y.; Nozaki, K.; Hashimoto, N.; Takagi, Y.; Dezawa, M. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J. Cerebr. Blood Flow Metabol. 2009, 29, 1409-1420.
101. Liu, Z.; Li, Y.; Zhang, X.; Savant-Bhonsale, S.; Chopp, M. Contralesional axonal remodeling of the corticospinal system in adult rats after stroke and bone marrow stromal cell treatment. Stroke 2008, 39, 2571-2577.
102. Chen, J.; Li, Y.; Katakowski, M.; Chen, X.; Wang, L.; Lu, D.; Lu, M.; Gautam, S.C.; Chopp, M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 2003, 73, 778-786.
103. Zhao, M.Z.; Nonoguchi, N.; Ikeda, N.; Watanabe, T.; Furutama, D.; Miyazawa, D.; Funakoshi, H.; Kajimoto, Y.; Nakamura, T.; Dezawa, M.; Shibata, M.A.; Otsuki, Y.; Coffin, R.S.; Liu, W.D.; Kuroiwa, T.; Miyatake, S. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J. Cerebr. Blood Flow Metabol. 2006, 26, 1176-1188.
104. Haas, S.; Weidner, N.; Winkler, J. Adult stem cell therapy in stroke. Curr. Opin. Neurol. 2005, 18, 59-64.
105. Roh, J.K.; Jung, K.H.; Chu, K. Adult stem cell transplantation in stroke: Its limitations and prospects. Curr. Stem Cell Res. Ther. 2008, 3, 185-196.
106. Li, Y.; McIntosh, K.; Chen, J.; Zhang, C.; Gao, Q.; Borneman, J.; Raginski, K.; Mitchell, J.; Shen, L.; Zhang, J.; Lu, D.; Chopp, M. Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats. Exp. Neurol. 2006, 198, 313-325.
107. Zhang, C.; Li, Y.; Chen, J.; Gao, Q.; Zacharek, A.; Kapke, A.; Chopp, M. Bone marrow stromal cells upregulate expression of bone morphogenetic proteins 2 and 4, gap junction protein connexin-43 and synaptophysin after stroke in rats. Neuroscience 2006, 141, 687-695.
108. Li, Y.; Chen, J.; Zhang, C. L.; Wang, L.; Lu, D.; Katakowski, M.; Gao, Q.; Shen, L. H.; Zhang, J.; Lu, M.; Chopp, M. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005, 49, 407-417.
109. Kubinova, S.; Sykova, E. Nanotechnology for treatment of stroke and spinal cord injury. Nanomedicine (Lond) 2010, 5, 99-108.
110. Lu, M.; Chen, J.; Lu, D.; Yi, L.; Mahmood, A.; Chopp, M. Global test statistics for treatment effect of stroke and traumatic brain injury in rats with administration of bone marrow stromal cells. J. Neurosci. Meth. 2003, 128, 183-190.
111. Hicks, A.; Schallert, T.; Jolkkonen, J. Cell-based therapies and functional outcome in experimental stroke. Cell Stem Cell 2009, 5, 139-140.
112. Li, Y.; Chopp, M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci. Lett. 2009, 456, 120-123.
113. Takahashi, K.; Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
114. Ogawa, Y.; Sawamoto, K.; Miyata, T.; Miyao, S.; Watanabe, M.; Nakamura, M.; Bregman, B.S.; Koike, M.; Uchiyama, Y.; Toyama, Y.; Okano, H. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res. 2002, 69, 925-933.
115. Perrier, A.L.; Tabar, V.; Barberi, T.; Rubio, M.E.; Bruses, J.; Topf, N.; Harrison, N.L.; Studer, L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2004, 101, 12543-12548.
116. Nisbet, D.R.; Moses, D.; Gengenbach, T.R.; Forsythe, J.S.; Finkelstein, D.I.; Horne, M.K. Enhancing neurite outgrowth from primary neurones and neural stem cells using thermoresponsive hydrogel scaffolds for the repair of spinal cord injury. J. Biomed. Mater. Res. A 2009, 89A, 24-35.
117. Song, S.J.; Song, S.J.; Zhang, H.L.; Cuevas, J.; Sanchez-Ramos, J. Comparison of neuron-like cells derived from bone marrow stem cells to those differentiated from adult brain neural stem cells. Stem Cells Dev. 2007, 16, 747-756.
118. Lee, H.; Shamy, G.A.; Elkabetz, Y.; Schofield, C.M.; Harrsion, N.L.; Panagiotakos, G.; Socci, N.D.; Tabar, V.; Studer, L. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007, 25, 1931-1939.
119. Keirstead, H.S.; Nistor, G.; Bernal, G.; Totoiu, M.; Cloutier, F.; Sharp, K.; Steward, O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 2005, 25, 4694-4705.
120. Ronsyn, M.W.; Daans, J.; Spaepen, G.; Chatterjee, S.; Vermeulen, K.; D'Haese, P.; Van Tendeloo, V.F.; Van Marck, E.; Ysebaert, D.; Berneman, Z.N.; Jorens, P.G.; Ponsaerts, P. Plasmid-based genetic modification of human bone marrow-derived stromal cells: Analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol. 2007, 7, 90.
121. Roy, N.S.; Cleren, C.; Singh, S.K.; Yang, L.; Beal, M.F.; Goldman, S.A. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomeraseimmortalized midbrain astrocytes. Nat. Med. 2006, 12, 1259-1268